# Laser 360iQ: Optimal Light-laser Combination Therapy

> **NCT04519723** · NA · COMPLETED · sponsor: **Alma Lasers Inc.** · enrollment: 8 (actual)

## Conditions studied

- Photodamage

## Interventions

- **DEVICE:** Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination .

## Key facts

- **NCT ID:** NCT04519723
- **Lead sponsor:** Alma Lasers Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519723, "Laser 360iQ: Optimal Light-laser Combination Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04519723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*